Form 4: Mesa Laboratories CEO Gary Owens Reports Stock Transactions Including RSU Vesting and Tax-Related Sale
Insider Transaction Report
Mesa Laboratories' President and CEO, Gary M. Owens, reported the acquisition of shares through RSU vesting and performance share units, followed by a sale of shares to cover income tax obligations.
Summary
- Gary M. Owens, President and CEO of Mesa Laboratories Inc. (MLAB), reported changes in his beneficial ownership of company common stock.
- On June 15, 2025, Mr. Owens acquired 2,324 shares of common stock upon the vesting of Restricted Stock Units (RSUs). These RSUs vested 1/3 on June 15, 2023, and on each of the next two anniversary dates.
- Also on June 15, 2025, Mr. Owens acquired an additional 2,102 shares of common stock from the release of performance share units issued under the FY23 program.
- Following these acquisitions, his direct beneficial ownership increased to 47,763 shares.
- On June 16, 2025, Mr. Owens sold 1,939 shares of common stock at a price of $97.118 per share.
- This sale was explicitly stated to cover income tax obligations related to the vested shares.
- After all reported transactions, Mr. Owens' direct beneficial ownership stands at 45,824 shares of common stock.
Sentiment
Score: 5
Explanation: Neutral. The document reports routine insider transactions (vesting and tax-related sale) which are common and do not inherently indicate positive or negative company performance or outlook.
Positives
- Vesting of Restricted Stock Units and performance share units indicates continued compensation and alignment of management interests with shareholders.
Negatives
- Sale of shares, even for tax purposes, reduces the CEO's direct ownership slightly.
Future Outlook
NA
Industry Context
NA
Stakeholder Impact
- Shareholders: Minor dilution from new shares issued for vesting, but also a routine sale by a key executive. Overall impact is minimal as these are standard compensation events.
Key Dates
| Date | Description |
|---|---|
| 06/15/2023 | First vesting date for a portion of Restricted Stock Units (RSUs). |
| 06/15/2025 | Vesting date for 2,324 Restricted Stock Units and release of 2,102 performance share units. |
| 06/16/2025 | Date of sale of 1,939 shares of common stock to cover income tax obligations. |
| 06/18/2025 | Date the Form 4 was signed by John Sakys under Power of Attorney for Gary Owens. |
Keywords
Mesa Laboratories, MLAB, Gary Owens, SEC Form 4, Insider Trading, Stock Transaction, Restricted Stock Units, RSU Vesting, Performance Share Units, CEO Stock Sale, Beneficial Ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.